Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
Clinical trial NCT03754530 · UNKNOWN
Trial details
- NCT number
- NCT03754530
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-06-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.